Cargando…

Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma

BACKGROUND: Evidence from prevailing studies show that hepatocellular carcinoma (HCC) is among the top cancers with high mortality globally. Gene regulation at post-transcriptional level orchestrated by RNA-binding proteins (RBPs) is an important mechanism that modifies various biological behaviors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Siyuan, Liu, Jingyi, Sun, Keshuai, Liu, Yansheng, Yu, Jiahao, Ma, Shuoyi, Zhang, Miao, Jia, Gui, Zhou, Xia, Shang, Yulong, Han, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870868/ https://www.ncbi.nlm.nih.gov/pubmed/33575212 http://dx.doi.org/10.3389/fonc.2020.597996

Ejemplares similares

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

Systematic Construction and Validation of a Prognostic Model for Hepatocellular Carcinoma Based on Immune-Related Genes
por: Yu, Jiahao, et al.
Publicado: (2021)

A nomogram based on pretreatment clinical parameters for the prediction of inadequate biochemical response in primary biliary cholangitis
por: Tian, Siyuan, et al.
Publicado: (2020)

An enhanced level of LAMP-2A participates in CD4(+)T cell hyperactivity in patients with primary biliary cholangitis
por: Sun, Keshuai, et al.
Publicado: (2021)

Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophages
por: Tian, Siyuan, et al.
Publicado: (2022)

Construction and validation of a prognostic model with RNA binding protein-related mRNAs for the HBV-related hepatocellular carcinoma patients
por: Xu, Shaohua, et al.
Publicado: (2022)

Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis
por: Han, Fang, et al.
Publicado: (2023)

Immunoglobulin M: A Neglected Serum Biomarker in Treatment‐Naive Primary Biliary Cholangitis With Normal Alkaline Phosphatase
por: Ding, Dawei, et al.
Publicado: (2022)

Construction and validation of a nomogram for predicting the prognosis of patients with lymph node-positive invasive micropapillary carcinoma of the breast: based on SEER database and external validation cohort
por: Li, Yifei, et al.
Publicado: (2023)

Construction and validation of an RNA-binding protein-associated prognostic model for colorectal cancer
por: Miao, Yandong, et al.
Publicado: (2021)

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients
por: Jia, Bin, et al.
Publicado: (2023)

Symptoms Burden and Health-related Quality of Life in Chinese Patients with Primary Biliary Cholangitis
por: Liu, Yansheng, et al.
Publicado: (2021)

Development and Validation of Epigenetic Modification-Related Signals for the Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Lu, Maoqing, et al.
Publicado: (2021)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

Construction and validation of a prognostic model of pyroptosis related genes in hepatocellular carcinoma
por: Li, Guanqun, et al.
Publicado: (2022)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

A novel signature constructed by super-enhancer-related genes for the prediction of prognosis in hepatocellular carcinoma and associated with immune infiltration
por: Wei, Xueyan, et al.
Publicado: (2023)

Clinical prognosis of intraoperative blood salvage autotransfusion in liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis
por: Wang, Zheng, et al.
Publicado: (2022)

Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer
por: You, Weiqiang, et al.
Publicado: (2022)

Construction of a DDR-related signature for predicting of prognosis in metastatic colorectal carcinoma
por: Wei, Maohua, et al.
Publicado: (2023)

Construction and Validation of Novel Nomograms for Predicting Prognosis of Pancreatic Ductal Adenocarcinoma After Surgery According to Different Primary Cancer Locations
por: Li, Ge, et al.
Publicado: (2021)

Construction and validation of a metabolic-associated lncRNA risk index for predicting colorectal cancer prognosis
por: Lin, Quanjun, et al.
Publicado: (2023)

Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach
por: Fei, Xiaobin, et al.
Publicado: (2022)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Construction and validation of a prediction model of extrahepatic metastasis for hepatocellular carcinoma based on common clinically available data
por: Zhou, Liuxin, et al.
Publicado: (2022)

Analysis of risk factors of hepatocellular carcinoma and establishment of a clinical prognosis model
por: Ge, Xin-Yu, et al.
Publicado: (2023)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer
por: Zhao, Lei, et al.
Publicado: (2023)

Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes
por: Yan, Cheng, et al.
Publicado: (2022)

Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma
por: Pan, Yu, et al.
Publicado: (2021)

Construction and Validation of Novel Prediction Tools Based on Large Population-Based Database to Predict the Prognosis of Urachal Cancer After Surgery
por: Yu, Xiaowen, et al.
Publicado: (2021)

A novel nomogram based on GD for predicting prognosis in hepatocellular carcinoma
por: Liu, Ying, et al.
Publicado: (2023)

Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma
por: Peng, Jie, et al.
Publicado: (2022)

Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022)

An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma
por: Lin, Zhuo, et al.
Publicado: (2021)

Immune-Related lncRNAs to Construct Novel Signatures and Predict the Prognosis of Rectal Cancer
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Ze-Kun, et al.
Publicado: (2022)

Tumor purity–associated genes influence hepatocellular carcinoma prognosis and tumor microenvironment
por: Zhao, Yan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1sjsfkuk6rvsu9npt79e5etko2